by CheckRare Staff | Nov 11, 2026
In this episode, we discuss highlights from The Liver Meeting, Ultragenyx program cuts, and ANI Pharmaceuticals’ offer to buy Egetis Therapeutics. Ultragenyx Ends Angelman Syndrome and Wilson Disease Programs Ultragenyx announced this week that...
by CheckRare Staff | Nov 10, 2026
Myasthenia gravis (MG) is a chronic autoimmune disease that disrupts communication between nerves and muscles, causing fluctuating weakness that often worsens with activity. It can affect the muscles controlling the eyes, face, speech, swallowing, limbs, and...
by CheckRare Staff | Nov 6, 2026
C3G and the Pediatric VALIANT Study Bradley Dixon, MD Bradley Dixon, MD, a pediatric nephrologist, and Chief of Pediatric Nephrology, Children’s Hospital of Colorado, and Professor of Pediatrics, University of Colorado School of Medicine, discusses complement 3...
by CheckRare Staff | Nov 4, 2026
In this episode, we discuss a new formulation of treatment for HAE, the FDA approval of Voceryq for recurrent respiratory papillomatosis, and 3D printed treatment options. New Formulation for HAE Approved The FDA has approved a new oral pellet...
by CheckRare Staff | Oct 30, 2026
Generalized Myasthenia Gravis: AANEM 2026 HighlightsKey data updates, therapeutic strategies, and evolving standards of care in generalized myasthenia gravis The American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) held its 2026 annual meeting...